Treatment of stage I and II non-small-cell lung cancer

Cancer Control

Volumn 8, Issue 4, 2001, Pages 318-325

  Smythe, W Roy ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PLATINUM DERIVATIVE;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER CONTROL; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC IMAGING; GENE THERAPY; HUMAN; LUNG NON SMALL CELL CANCER; SURGICAL APPROACH; TREATMENT PLANNING;

EID: 0034928808     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480100800403     Document Type: Article

References (52)

1. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer
2. Survival in early-stage non-small cell lung cancer
3. Prognosis and survival in resected lung carcinoma based on the new international staging system
4. Revisions in the international system for staging lung cancer
5. Preoperative staging of non-small-cell lung cancer with positron-emission tomography
6. Analysis of published studies on the detection of extrathoracic metastases in patients presumed to have operable non-small cell lung cancer
7. Cerebral metastases from lung carcinoma: Neurological and CT correlation. Work in progress
8. Cerebral tumor staging in patients with bronchial carcinoma by computed tomography
9. Detection of brain metastasis in potentially operable non-small cell lung cancer: A comparison of CT and MRL
10. The ambiguity and the exigency: Clarifying "standard of care" arguments in international research
11. Comparison of lobectomy and wedge resection for carcinoma of the lung
12. Wedge resection as an alternative procedure for peripheral bronchogenic carcinoma in poor-risk patients
13. Primary lung carcinoma: Results with conservative resection in treatment
14. Incidence of local recurrence and second primary tumors in resected stage I lung cancer
15. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer
16. One hundred video-assisted thoracic surgical simultaneously stapled lobectomies without rib spreading
17. Pulmonary function after lobectomy: Video-assisted thoracic surgery versus thoracotomy
18. Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter
19. Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter
20. Lymph node metastasis in small peripheral adenocarcinoma of the lung
21. Radical radiotherapy for early nonsmall cell lung cancer
22. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer
23. Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer
24. Intraoperative lymphatic mapping for non-small cell lung cancer: The sentinel node technique
25. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: A retrospective analysis of 149 patients
26. Prognostic factors in the treatment of node-negative non-small lung carcinoma with radiotherapy alone
27. Proton-beam radiotherapy for early-stage lung cancer
28. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised trials
29. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
30. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer
31. Results of cancer and leukemia group B protocol 8935: A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer
32. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805
33. Randomized trial of chemotherapy followed by surgery versus surgery for stage IIIA N2 non-small cell lung cancer: The Japan Clinical Oncology Group 9209
34. Randomized phase 2 evaluation of preoperative radiation therapy and preoperative chemotherapy with mitomycin, vinblastine, and cisplatin in patients with technically unresectable stage IIIA and IIIB non-small cell cancer of the lung: LCSG 881
35. A phase III comparison of "best local-regional therapy" with or without chemotherapy (CT) for stage IIIA T1-3N2 non-small cell lung cancer (NSCLC): Preliminary results
36. Preoperative chemotherapy for lung cancer does not increase surgical morbidity
37. Induction chemotherapy before surgery for early-stage lung cancer: A novel approach
38. Autopsy diagnoses of malignant neoplasms: How often are clinical diagnoses incorrect?
39. Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer
40. Detection of extrathoracic metastases by positron emission tomography in lung cancer
41. Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer
42. Detection of occult metastases in lung carcinomas: Progress and implications for lung cancer staging
43. Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer
44. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases
45. Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer
46. Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small-cell lung cancer
47. Early lung cancer action project: Overall design and findings from baseline screening
48. Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer
49. Primary peripheral lung carcinoma smaller than 1 cm in diameter
50. Metabolic staging of lung cancer
51. Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patients
52. Gene therapy for non-small cell lung cancer: A preliminary report of a phase I trial of adenoviral p53 gene replacement